Pro‐inflammatory cytokines such as IL‐1β and TNF‐α further amplify this effect by stimulating both NF‐κB signaling, and ABCG2 expression in certain breast cancer cell lines, suggesting a coordinated response involved in drug resistance [45]. This evidence concerns the gene NFKB1 and breast cancer.